Tissue PD-L1 interaction with PD-1 on T cells triggers low-level production of Mito-ROS and allows GSH/Myc pathways to promote metabolic reprogramming with increased Glyco-ATP and Mito-ATP, leading to robust T cell expansion and survival and induction of GVHD. The gene discussed is MYC; the disease is graft versus host disease.